WHO-GMP Certified Commercial Pack · Product Code: AKP-032
Terbutaline Sulphate 1.25mg, Bromhexine HCl 2mg, Guaiphenesin 50mg & Menthol 0.5mg Syrup (per 5ml)
Formulation Overview: Quadruple-action bronchodilator and mucolytic expectorant syrup combining beta-2 smooth muscle relaxation, mucus viscosity cleavage, ciliary clearance, and soothing menthol cooling. Formulated with Terbutaline Sulphate IP 1.25 mg + Bromhexine HCl IP 2 mg + Guaiphenesin IP 50 mg + Menthol IP 0.5 mg (1.25 mg + 2 mg + 50 mg + 0.5 mg / 5 ml) in Oral Expectorant Syrup dosage form under Respiratory & Allergy, manufactured to IP / BP / USP Compendial standards and supplied in 100 ml Amber PET Bottle with Pilfer-Proof Cap & Measuring Cup with complete eCTD/ACTD regulatory dossiers, Zone IVb stability, and batch CoA for African NRAs (NAFDAC, PPB, SAHPRA, TMDA, FDA Ghana) and global tenders.
| Item Code (SKU) | AKP-032 |
|---|---|
| Therapeutic Sector | Respiratory & Allergy |
| Dosage Form | Oral Expectorant Syrup |
| Active Ingredient | Terbutaline Sulphate IP 1.25 mg + Bromhexine HCl IP 2 mg + Guaiphenesin IP 50 mg + Menthol IP 0.5 mg |
| Strength / Purity | 1.25 mg + 2 mg + 50 mg + 0.5 mg / 5 ml |
| Clinical Indication | Productive cough associated with acute bronchitis, asthma, and COPD mucus hypersecretion |
| Specification Standard | IP / BP / USP Compendial |
| Packaging Format | 100 ml Amber PET Bottle with Pilfer-Proof Cap & Measuring Cup |
| Shelf Life | 24–36 Months |
| Storage Conditions | Store below 25°C; protect from light; shake well before use |
| Minimum Order Quantity | 1000 Packs |
| Regulatory / Analytical Docs | Full eCTD / ACTD Modules 1–5 + Zone IVb Stability Available |
| African & Global NRA Readiness | NAFDAC (Nigeria), PPB (Kenya), SAHPRA (SA), TMDA (Tanzania), FDA Ghana, AIRP, ARP, EFDA |
| Stock Availability | In Stock · Immediate Commercial Dispatch |
| Supply Status | Commercial Export Ready |